1. Effect of epigallocatechin-3-gallate on inflammatory mediators release in LPS-induced Parkinson’s disease in rats;Al-Amri;Indian J Exp Biol,2013
2. Synaptic dysfunction in synucleinopathies;Anichtchik;CNS Neurol Disord Drug Targets,2013
3. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies;Baba;Am J Pathol,1998
4. Experimental models of Parkinson’s disease: from the static to the dynamic;Bezard;Rev Neurosci,1998
5. A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases;Borza;Rev Med Chir Soc Med Nat Iasi,2014